Firefly Neuroscience, Inc.
AIFF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 29.8% | 595.3% | -18.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 37.6% | 91.6% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -619.3% | -592.3% | -29,727.9% | -4,826.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -680.2% | -613% | -30,069.8% | -7,141.5% |
| EPS Diluted | -0.2 | -0.14 | -1.74 | -0.45 |
| % Growth | -42.9% | 92% | -286.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |